Search

Your search keyword '"Murata, Kohei"' showing total 737 results
Start Over Author "Murata, Kohei"
737 results on '"Murata, Kohei"'

1. Robotic versus open and laparoscopic pelvic exenterations for pelvic cancer: a multicenter propensity-matched analysis in Japan

Author

Yatabe, Yusuke, Hanaoka, Marie, Hanazawa, Ryoichi, Hirakawa, Akihiro, Mukai, Toshiki, Kimura, Kei, Yamanoi, Koji, Kono, Jin, Yokota, Mitsuru, Takahashi, Hiroki, Kobayashi, Akihiro, Kobayashi, Kenji, Ichikawa, Nobuki, Yasui, Masayoshi, Nakane, Keita, Yamamoto, Manabu, Takenaka, Atsushi, Nakamura, Yuya, Takemasa, Ichiro, Yabusaki, Norimitsu, Akamoto, Shintaro, Tatarano, Shuichi, Murata, Kohei, Manabe, Tatsuya, Fujimura, Tetsuya, Kawamura, Mikio, Egi, Hiroyuki, Yamaguchi, Shigeki, Terai, Yoshito, Inoue, Shigetaka, Ito, Akihiro, and Kinugasa, Yusuke

Published
2024
Full Text
View/download PDF

3. Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer

Author

Kato, Takeshi, Kudo, Toshihiro, Kagawa, Yoshinori, Murata, Kohei, Ota, Hirofumi, Noura, Shingo, Hasegawa, Junichi, Tamagawa, Hiroshi, Ohta, Katsuya, Ikenaga, Masakazu, Miyazaki, Susumu, Komori, Takamichi, Uemura, Mamoru, Nishimura, Junichi, Hata, Taishi, Matsuda, Chu, Satoh, Taroh, Mizushima, Tsunekazu, Ohno, Yuko, Yamamoto, Hirofumi, Doki, Yuichiro, and Eguchi, Hidetoshi

Published
2023
Full Text
View/download PDF

4. Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903)

Author

Ito, Yoshinori, Hamaguchi, Tetsuya, Takashima, Atsuo, Mizusawa, Junki, Shimada, Yasuhiro, Shiozawa, Manabu, Mizoguchi, Nobutaka, Kodaira, Takeshi, Komori, Koji, Ohue, Masayuki, Konishi, Koji, Teraishi, Fuminori, Kinouchi, Makoto, Murata, Kohei, Fujita, Fumihiko, Watanabe, Masahiko, Iinuma, Gen, Ishida, Fumio, Saida, Yoshihisa, Matsuda, Takahisa, Katayama, Hiroshi, Fukuda, Haruhiko, and Kanemitsu, Yukihide

Published
2023
Full Text
View/download PDF

6. Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study

Author

Shiota, Tetsuya, Murata, Kohei, Kishimoto, Mitsuo, Yao, Takashi, Noura, Shingo, Morita, Shunji, Akiyoshi, Takashi, Okamura, Shu, Imasato, Mitsunobu, Furuhata, Tomohisa, Suto, Takeshi, Takemasa, Ichiro, Shingai, Tatsushi, Ueda, Masami, Mizuno, Hitoshi, Hisamatsu, Yuichi, Takeda, Takashi, Fujii, Makoto, Kagawa, Yoshinori, and Sugihara, Kenichi

Published
2023
Full Text
View/download PDF

9. Tolerability and Safety Assessment of Adjuvant Chemoradiotherapy with S-1 after Limited Surgery for T1 or T2 Lower Rectal Cancer.

Author

Miyoshi, Norikatsu, Uemura, Mamoru, Noura, Shingo, Yasui, Masayoshi, Nishimura, Junichi, Tei, Mitsuyoshi, Matsuda, Chu, Morita, Shunji, Inoue, Akira, Tamagawa, Hiroki, Mokutani, Yukako, Yoshioka, Shinichi, Fujii, Makoto, Kato, Shinya, Sekido, Yuki, Ogino, Takayuki, Yamamoto, Hirofumi, Murata, Kohei, Doki, Yuichiro, and Eguchi, Hidetoshi

Subjects
THERAPEUTIC use of antineoplastic agents, PATIENT safety, ANUS, ADJUVANT treatment of cancer, EARLY detection of cancer, CHEMORADIOTHERAPY, TREATMENT effectiveness, CANCER patients, RECTUM tumors, LONGITUDINAL method, RESEARCH, PROGRESSION-free survival, DRUG tolerance, OVERALL survival
Abstract

Simple Summary: The study evaluated the long-term outcomes of chemoradiotherapy (CRT) with S-1 after limited surgery for T1 or T2 lower rectal cancer. The 3-year and 5-year relapse-free survival rates were 90.17% and 85.87%, respectively, showing favorable outcomes for T1 cancer patients, with effective anal function preservation. However, further treatment is needed to improve outcomes for T2 cancer patients. Background: The short-term outcomes of chemoradiotherapy (CRT) with S-1 (a combination of tegafur, gimeracil, and oteracil) following limited surgery for patients with T1 or T2 lower rectal cancer have shown encouraging results. Objectives: This study was designed to delve deeper into the long-term outcomes of CRT with S-1 after limited surgery, with the goal of evaluating both the long-term efficacy and potential risks associated with this treatment approach in patients diagnosed with T1 or T2 lower rectal cancer. Methods: This was conducted as a multicenter, single-arm, prospective phase II trial. The patient population consisted of individuals clinically diagnosed with either T1 or T2 lower rectal or anal canal cancer, with a maximum tumor diameter of 30 mm and classified as N0 or M0. Patients underwent local excision or endoscopic resection. After surgery, CRT with S-1 was administered to patients meeting several criteria, including the confirmation of well-differentiated or moderately differentiated adenocarcinoma, negative surgical margins, submucosal invasion depth of ≥1000 µm, and high tumor-budding grade (2/3). The primary endpoint of this study was relapse-free survival, while secondary endpoints included local recurrence-free survival, overall survival, anal sphincter preservation rate, and safety. Results: A total of 52 patients were included, with pathological diagnoses revealing T1 in 36 patients and T2 in 16 patients. The 3-year and 5-year relapse-free survival rates were 90.17% and 85.87%, respectively. The 3-year and 5-year local recurrence-free survival rates were 90.17% and 88.07%, respectively, while the 3-year and 5-year overall survival rates were 94.03% and 91.94%, respectively. Conclusions: CRT with S-1 after limited surgery for T1 lower rectal cancer demonstrated favorable outcomes in terms of recurrence, survival, and local control rates while effectively maintaining anal function in patients. However, further treatment approaches may be necessary to improve outcomes for patients diagnosed with stage T2 lower rectal cancer [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Clinical Significance of Lymph Node Dissection and Lymph Node Metastasis in Primary Appendiceal Tumor Patients After Curative Resection: a Retrospective Multicenter Cohort Study

Author

Takeyama, Hiroshi, Murata, Kohei, Takeda, Takashi, Fujii, Makoto, Kagawa, Yoshinori, Kawachi, Hiroshi, Yamaguchi, Tatsuro, Noura, Shingo, Masuishi, Toshiki, Inoue, Akira, Takii, Yasumasa, Suto, Takeshi, Sakamoto, Kazuhiro, Tei, Mitsuyoshi, Kishimoto, Mitsuo, Yao, Takashi, and Sugihara, Kenichi

Published
2022
Full Text
View/download PDF

13. Safety and feasibility of minimally invasive distal pancreatectomy for pancreatic cancer in elderly patients: A retrospective study.

Author

Aoyama, Shu, Ohmura, Yoshiaki, Takeda, Yutaka, Katsura, Yoshiteru, Kinoshita, Mitsuru, Shinke, Go, Kihara, Yukari, Yanagisawa, Kiminori, Katsuyama, Shinsuke, Ikeshima, Ryo, Hiraki, Masayuki, Sugimura, Keijiro, Masuzawa, Toru, Hata, Taishi, and Murata, Kohei

Subjects
PANCREATECTOMY, OLDER patients, PANCREATIC cancer, CANCER patients, SURGICAL complications, PANCREATIC fistula
Abstract

Introduction: Previous studies have not evaluated the surgical difficulty of minimally invasive distal pancreatectomy for pancreatic cancer in elderly patients. Therefore, we aimed to investigate the effect of elderly age on the perioperative outcomes of minimally invasive distal pancreatectomy, focusing on surgical difficulty. Methods: This single‐center retrospective study included patients who underwent minimally invasive distal pancreatectomy for pancreatic cancer at Kansai Rosai Hospital between September 2012 and December 2023. Perioperative outcomes were investigated between the elderly (>75 years) and non‐elderly (≤75 years) groups. Results: Fifty‐six patients were included: 26 and 30 in the elderly and non‐elderly groups, respectively. The median operative time was significantly shorter in the elderly group than in the non‐elderly group (324 vs. 414 min, p =.022), but other surgical outcomes were not significantly different including oncological factors. The median difficulty score was similar between the elderly and non‐elderly groups (6 vs. 7, respectively; p =.699). The incidences of postoperative complications and pancreatic fistulas were not significantly different in the elderly and non‐elderly groups (23% vs. 43%, p =.159, and 19% vs. 36%, p =.236, respectively), even though analyzed in subgroups with low‐to‐intermediate or high difficulty score. Conclusions: The safety and feasibility of minimally invasive distal pancreatectomy for pancreatic cancer were not significantly different between elderly and non‐elderly patients, even when surgical difficulty was considered. This surgical procedure can be safe and feasible for elderly patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Minimally invasive liver resection for cholangiolocellular carcinoma: A single‐institution experience

Author

Kihara, Yukari, primary, Takeda, Yutaka, additional, Ohmura, Yoshiaki, additional, Katsura, Yoshiteru, additional, Shinke, Go, additional, Kinoshita, Mitsuru, additional, Aoyama, Shu, additional, Yanagisawa, Kiminori, additional, Katsuyama, Shinsuke, additional, Ikeshima, Ryo, additional, Hiraki, Masayuki, additional, Sugimura, Keijiro, additional, Masuzawa, Toru, additional, Hata, Taishi, additional, and Murata, Kohei, additional

Published
2023
Full Text
View/download PDF

21. Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter Study

Author

Itabashi, Michio, Yamamoto, Hirofumi, Tomita, Naohiro, Inomata, Masafumi, Murata, Kohei, Hayashi, Shigeoki, Miyake, Yasuhiro, Igarashi, Seiji, Kato, Takeshi, Noura, Shingo, Furuhata, Tomohisa, Ozawa, Heita, Takemasa, Ichiro, Yasui, Masayoshi, Takeyama, Hiroshi, Okamura, Shu, Ohno, Yuko, and Matsuura, Nariaki

Published
2020
Full Text
View/download PDF

25. Usefulness of blood flow evaluation by indocyanine green fluorescence in laparoscopic or robot‐assisted surgery for colorectal cancer with persistent descending mesocolon

Author

Kusafuka, Hiroshi, primary, Hiraki, Masayuki, additional, Kawai, Kenji, additional, Ikeshima, Ryo, additional, Hata, Taishi, additional, Yanagisawa, Kiminori, additional, Kinoshita, Mitsuru, additional, Katsuyama, Shinsuke, additional, Shinke, Go, additional, Ohmura, Yoshiaki, additional, Sugimura, Keijiro, additional, Masuzawa, Toru, additional, Takeda, Yutaka, additional, and Murata, Kohei, additional

Published
2023
Full Text
View/download PDF

26. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial

Author

Kitano, Seigo, Inomata, Masafumi, Mizusawa, Junki, Katayama, Hiroshi, Watanabe, Masahiko, Yamamoto, Seiichiro, Ito, Masaaki, Saito, Shuji, Fujii, Shoichi, Konishi, Fumio, Saida, Yoshihisa, Hasegawa, Hirotoshi, Akagi, Tomonori, Sugihara, Kenichi, Yamaguchi, Takashi, Masaki, Tadahiko, Fukunaga, Yosuke, Murata, Kohei, Okajima, Masazumi, Moriya, Yoshihiro, and Shimada, Yasuhiro

Published
2017
Full Text
View/download PDF

27. Minimally invasive liver resection for cholangiolocellular carcinoma: A single‐institution experience.

Author

Kihara, Yukari, Takeda, Yutaka, Ohmura, Yoshiaki, Katsura, Yoshiteru, Shinke, Go, Kinoshita, Mitsuru, Aoyama, Shu, Yanagisawa, Kiminori, Katsuyama, Shinsuke, Ikeshima, Ryo, Hiraki, Masayuki, Sugimura, Keijiro, Masuzawa, Toru, Hata, Taishi, and Murata, Kohei

Subjects
LIVER surgery, LYMPHADENECTOMY, LIVER, LAPAROSCOPIC surgery, PROGRESSION-free survival, OVERALL survival
Abstract

Introduction: Cholangiolocellular carcinoma (CoCC) resembles cholangiocellular carcinoma (CCC) and presents a variety of imaging findings; thus, preoperative diagnosis is often difficult. Methods: We retrospectively studied patients who were diagnosed with CoCC at the Kansai Rosai Hospital from 2006 to 2021 and treated by laparoscopic liver resection (LLR) or open liver resection (OLR). Result: Among 918 liver resections, 15 patients were diagnosed with CoCC: 11 underwent LLR and 4 OLR. For LLR and OLR, respectively, patient age was 69.9 ± 6.8 and 72.8 ± 10.6, sex was M/F: 10/1 and 2/2, Child‐Pugh was A/B/C: 10/1/0 and 4/0/0, liver damage was A/B/C: 8/3/0 and 4/0/0, preoperative diagnosis was CoCC/CCC/HCC: 1/2/8 and 2/2/0, pathological stage of Union for International Cancer Control (UICC) was IA/IB/II/IIIA/IIIB/IV: 8/0/2/1/0/0 and 0/0/3/0/1/0 (p =.0312), and extent of liver resection was Hr0/HrS/Hr1/Hr2/: 3/0/5/3 and 1/1/0/2. In LLR and OLR, respectively, operation time was 417.5 ± 191.0 and 407.5 ± 187.9 min, blood loss was 123.3 ± 217.4 and 1385.0 ± 1038.7 mL, and postoperative hospital stay was 12.2 ± 13.7 and 15.0 ± 6.6 days. For stages I and II/III, respectively, the 5‐year disease‐free survival rates were 100.0% and 34.3%, and the 5‐year overall survival rates were 100.0% and 55.6%. For stage II/III LLR and OLR, respectively, the 3‐year disease‐free survival rates were 33.3% and 37.5% (p =.8418), and the 5‐year overall survival rates were 66.7% and 50.0% (p =.8084). Conclusion: Although further studies are still needed to confirm, minimally invasive liver resection without lymph node dissection is one of a safe and effective approach to the management of CoCC. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Supplementary Figure 2 from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Data from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

33. Data from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 1 from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 2 from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure Legend from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Table 1 from Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

Author

Takeyama, Hiroshi, primary, Yamamoto, Hirofumi, primary, Yamashita, Shinya, primary, Wu, Xin, primary, Takahashi, Hidekazu, primary, Nishimura, Junichi, primary, Haraguchi, Naotsugu, primary, Miyake, Yasuhiro, primary, Suzuki, Rei, primary, Murata, Kohei, primary, Ohue, Masayuki, primary, Kato, Takeshi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ishii, Hideshi, primary, Mimori, Koshi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

38. The proteasome activities of LPACs and non-LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

39. The list of universally elevated genes in LPACｓ of all cell lines using microarray analysis. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

40. Analysis of LPACs and non-LPACs based on various stem cell markers. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

41. The confirmation of stable ZsGreen expression in CRC cell lines. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

42. The validation of over-expression of EID3 and down- regulation of EID3. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

43. Relationship between EID3 expression and clinicopathological factors in patients with colorectal cancer from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

44. LPACs were not detected transitioning from non-LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

45. Validation of EID3 expression in LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Author

Munakata, Koji, primary, Uemura, Mamoru, primary, Tanaka, Shinji, primary, Kawai, Kenji, primary, Kitahara, Tomohiro, primary, Miyo, Masaaki, primary, Kano, Yoshihiro, primary, Nishikawa, Shinpei, primary, Fukusumi, Takahito, primary, Takahashi, Yusuke, primary, Hata, Taishi, primary, Nishimura, Junichi, primary, Takemasa, Ichiro, primary, Mizushima, Tsunekazu, primary, Ikenaga, Masakazu, primary, Kato, Takeshi, primary, Murata, Kohei, primary, Carethers, John M., primary, Yamamoto, Hirofumi, primary, Doki, Yuichiro, primary, and Mori, Masaki, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results